UY25197A1 - Un procedimiento para mejorar la producción de 5r clavams - Google Patents

Un procedimiento para mejorar la producción de 5r clavams

Info

Publication number
UY25197A1
UY25197A1 UY25197A UY25197A UY25197A1 UY 25197 A1 UY25197 A1 UY 25197A1 UY 25197 A UY25197 A UY 25197A UY 25197 A UY25197 A UY 25197A UY 25197 A1 UY25197 A1 UY 25197A1
Authority
UY
Uruguay
Prior art keywords
clavam
production
clavulanic acid
clavams
amoxicillin
Prior art date
Application number
UY25197A
Other languages
English (en)
Inventor
Barton Barry
Patrick Griffin John
Henry Mosher Roy
Ashish Paradkar
Cecilia Anders
Susan Jensen
Original Assignee
Smithkline Beecham P L C Y The Governors Of The Univ Of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P L C Y The Governors Of The Univ Of Alberta filed Critical Smithkline Beecham P L C Y The Governors Of The Univ Of Alberta
Publication of UY25197A1 publication Critical patent/UY25197A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a nuevos genes bacterianos y procedimiento para mejorar la fabricación de clavams, por ejemplo, ácido clavulánico útil como antibiótico. También proporciona nuevos organismos capaces de producir cantidades incrementadas de ácido clavulánico. Un proceso para mejorar la producción de 5R clavam en un microorganismo adecuado que comprende la manipulación de ADN que comprende uno o más genes específicos para la biosíntesis de 5R clavam en S. Clavuligerus que no es esencial para la biosíntesis de 5R clavam, y su inclusión en dicho microorganismo. Dicho proceso comprende la disrupción u otra manera de hacer defectuosas las regiones de ADN que flanquean a cas1. Se presenta un proceso en el que el 5S clavam es clavam-2-carboxilato y/o 2-hidroximetilclavam. Y un proceso para la preparación de una composición que comprende clavulnato de potasio y amoxicilina, comprendiendo dicho proceso la producción de ácido clavulánico y en adelante convertirlo en sal de potasio y la sal de potasio con amoxicilina.
UY25197A 1997-02-04 1998-09-30 Un procedimiento para mejorar la producción de 5r clavams UY25197A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9702218.0A GB9702218D0 (en) 1997-02-04 1997-02-04 Novel product
UY24874A UY24874A1 (es) 1997-02-04 1998-02-03 Nuevos compuestos

Publications (1)

Publication Number Publication Date
UY25197A1 true UY25197A1 (es) 1998-11-27

Family

ID=10807030

Family Applications (2)

Application Number Title Priority Date Filing Date
UY24874A UY24874A1 (es) 1997-02-04 1998-02-03 Nuevos compuestos
UY25197A UY25197A1 (es) 1997-02-04 1998-09-30 Un procedimiento para mejorar la producción de 5r clavams

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY24874A UY24874A1 (es) 1997-02-04 1998-02-03 Nuevos compuestos

Country Status (32)

Country Link
US (5) US6936458B1 (es)
EP (2) EP1405913A3 (es)
JP (2) JP4227199B2 (es)
KR (2) KR100514964B1 (es)
CN (2) CN1192107C (es)
AP (1) AP1320A (es)
AR (2) AR011100A1 (es)
AT (1) ATE312926T1 (es)
AU (1) AU735782B2 (es)
BG (1) BG103704A (es)
BR (1) BR9807144A (es)
CA (1) CA2279207A1 (es)
DE (1) DE69832783T2 (es)
DZ (1) DZ2413A1 (es)
EA (1) EA003773B1 (es)
ES (1) ES2255149T3 (es)
GB (1) GB9702218D0 (es)
HU (1) HUP0001048A3 (es)
ID (1) ID22144A (es)
IL (1) IL131043A0 (es)
MA (1) MA24464A1 (es)
MY (1) MY140928A (es)
NO (1) NO993758D0 (es)
NZ (1) NZ336894A (es)
OA (1) OA11082A (es)
PL (1) PL334961A1 (es)
SK (1) SK105499A3 (es)
TR (1) TR199901862T2 (es)
TW (2) TW200307041A (es)
UY (2) UY24874A1 (es)
WO (1) WO1998033896A2 (es)
ZA (1) ZA98868B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019959A1 (en) * 1999-09-16 2001-03-22 The Johns Hopkins University Improvement of clavulanic acid production
EP1228218A2 (en) * 1999-10-22 2002-08-07 Smithkline Beecham Plc 5r clavam producing microorganisms with deleted lat and cvm genes
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
CN107964522B (zh) * 2018-01-04 2020-12-08 上海交通大学 海洋链霉菌dut11及其抗补体活性应用
CN114072493A (zh) 2019-07-05 2022-02-18 葛兰素史密斯克莱知识产权（第2 号）有限公司 棒状链霉菌

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
IT1059403B (it) * 1975-02-07 1982-05-31 Glaxo Lab Ltd Procedimento per produrre acido clavulanico e suoi derivati nonche composizioni che lo contengono
GB1585661A (en) 1976-06-08 1981-03-11 Glaxo Lab Ltd Clavam derivatives
JPS589679B2 (ja) 1977-02-24 1983-02-22 武田薬品工業株式会社 抗生物質の製造法
US4202819A (en) 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9020683D0 (en) 1990-09-22 1990-11-07 Univ Strathclyde Isolation of dna
CA2108113C (en) * 1993-10-08 2006-12-05 Susan E. Jensen Dna sequence encoding enzymes of clavulanic acid biosynthesis

Also Published As

Publication number Publication date
AR018304A2 (es) 2001-11-14
AP9901614A0 (en) 1999-09-30
DE69832783T2 (de) 2006-07-20
ID22144A (id) 1999-09-09
UY24874A1 (es) 2001-07-31
WO1998033896A2 (en) 1998-08-06
JP4227199B2 (ja) 2009-02-18
EP1405913A2 (en) 2004-04-07
HUP0001048A2 (hu) 2000-08-28
WO1998033896A3 (en) 1998-11-19
HUP0001048A3 (en) 2001-09-28
MA24464A1 (fr) 1998-10-01
JP2001511001A (ja) 2001-08-07
US20030166175A1 (en) 2003-09-04
JP5042186B2 (ja) 2012-10-03
US6936458B1 (en) 2005-08-30
US7344869B2 (en) 2008-03-18
NO993758L (no) 1999-08-03
US20030022321A1 (en) 2003-01-30
AR011100A1 (es) 2000-08-02
CN1192107C (zh) 2005-03-09
TW200307041A (en) 2003-12-01
DZ2413A1 (fr) 2003-01-04
ES2255149T3 (es) 2006-06-16
GB9702218D0 (en) 1997-03-26
AU735782B2 (en) 2001-07-12
TR199901862T2 (xx) 2000-12-21
IL131043A0 (en) 2001-01-28
PL334961A1 (en) 2000-03-27
EP0970198B1 (en) 2005-12-14
CN1696301A (zh) 2005-11-16
EP0970198A2 (en) 2000-01-12
KR20000070723A (ko) 2000-11-25
US20070298470A1 (en) 2007-12-27
ATE312926T1 (de) 2005-12-15
ZA98868B (en) 1999-08-03
EP1405913A3 (en) 2004-08-04
SK105499A3 (en) 2000-05-16
AU6295398A (en) 1998-08-25
NZ336894A (en) 2001-08-31
CA2279207A1 (en) 1998-08-06
TW589377B (en) 2004-06-01
EA199900718A1 (ru) 2000-02-28
AP1320A (en) 2004-10-29
JP2009022298A (ja) 2009-02-05
KR100514964B1 (ko) 2005-09-15
KR20050053794A (ko) 2005-06-08
EA003773B1 (ru) 2003-08-28
NO993758D0 (no) 1999-08-03
OA11082A (en) 2003-03-13
CN1251612A (zh) 2000-04-26
US20030124690A1 (en) 2003-07-03
DE69832783D1 (de) 2006-01-19
BG103704A (en) 2000-05-31
BR9807144A (pt) 2000-01-25
MY140928A (en) 2010-02-12

Similar Documents

Publication Publication Date Title
WO2002066667A8 (en) Glucosamine and method of making glucosamine from microbial biomass
AU5102899A (en) Process and materials for production of glucosamine
DE60029091D1 (de) Verfahren zur herstellung von diphtheria toxin
AU679978B2 (en) Enzymatic hydrolysis methods for the preparation of C-10 andC-13 hydroxyl-bearing taxanes, enzymatic esterification method for the preparation of C-10 acyloxy-bearing taxanes, and use thereof in the preparation of C-13 acyloxy-bearing taxanes
UY25197A1 (es) Un procedimiento para mejorar la producción de 5r clavams
ATE92532T1 (de) Verfahren zur herstellung von polysacchariden.
MY136899A (en) Method for producing copolyester
PT711349E (pt) Genes que codificam para o complexo desidrogenase de acido alfa-cetonico de cadeia ramificada a partir de streptomyces avermitilis
ATE486967T1 (de) Herstellung von thiamin durch fermentation
DE3884741T2 (de) Mikrobiologisches Verfahren zur Herstellung von UK-61.689 und Mikroorganismen zur Verwendung darin.
Hosseini Khayat et al. Production of clavulanic acid by Streptomyces clavuligerus in batch cultures with using wheat bran as the source of carbon
GB9424950D0 (en) Novel process
EP1229127B1 (de) Verfahren zur enzymatischen Herstellung von enantiomerenreinen 1,3-Dioxolan-4-on- und 1,3-Oxathiolan-5-on-Derivaten
ATE283362T1 (de) Verfahren zur erhöhung der produktion von clavam- antibiotika
Briant The Effect of Phosphate in the Production of Tetracycline by the Fermentation of Streptomyces aureofaciens
JPS5537136A (en) Preparation of cephalosporin antibiotic
WO1998002556A3 (en) Screening for and use of an esterase for a stereospecific resolution
ATE279527T1 (de) Verfahren zur herstellung von l-2- aminoadipinsäure
RU94031719A (ru) Способ получения биомассы микроорганизмов
Mori et al. Preparative Bioorganic Chemistry, XI Preparation of the Enantiomers of Paraconic Acid Employing Lipase‐Mediated Asymmetric Hydrolysis of Prochiral Diacetates as the Key Step
KR850007084A (ko) 항생물질의 제조방법
JPH0556777A (ja) ビタミンｂ▲１２▼要求性株の培養方法およびこれにより得られたビタミンｂ▲１２▼要求性株
ES2187219B1 (es) Mejora de cepas de streptomyces mediante la utilizacion de genes biosinteticos de acido clavulanico.
BRPI9816369C1 (pt) processo para produção de ácido araquidônico

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20180930